A Few Resources on Antibiotic Incentives Policy

Referring blog here, based on a policy release by Gottlieb/FDA.

Undated

DRIVE AB: Incentives...23pp...here. See also:   http://drive-ab.eu/ 

2014

Innovation of novel antibiotics: Economic perspective.  McKellar & Fendrick, Clin Infect Dis (open access), here.

2015

Time for a change...addressing R&D and commercialization challenges... Phil Trans Roy Soc Lond (open access), Payne et al., here.
Novel approaches are needed...Am J Resp Crit Care Med, Spellberg et al., (open access) here.
Antibiotic R&D: Business as usual?  J Antimic Chemother, Harbarth, here.

2016

For a 2016 G7 incentives declaration, Ise-Shima Summit, 32pp, here.

Book:
Superbugs, Harvard Univ Press, here, authors: Hall, McDonnell, O'Neill.
   Review, Jerome Groopman MD, at NY Rev Books, June 2018, here.

Funding antibiotic innovation with vouchers... Outterson & McDonnell, Health Affairs, here.
   Outterson directs CARB-X, funded by BARDA.

Critical review of (European/British Infectious Disease Financing Facility, IDFF)...Global Health, Brogan & Mossialos, here.

Systems, not pills: Options market...pipeline.   Soc Sci Med, Brogan & Mossialos, here.

Systematic review and critical assessment...J Antibiot (Tok), Renwick et al., (open access), here.

Economic incentives...Transatlantic task force (TATFAR)...Clin Infect Dis, Sciarretta et al., open access, here.

2017

Incentivising innovation in antibiotic drug discovery...Simpkin, J Antibiotics (open access), here.

The antibiotic pipeline: Revising R&D...Exp Rev Anti Infect Ther, Luepke & Mohr, here.

Past, present future of antibacterial economics...Pharmacotherapy, Luepke et al., here.

Antibiotic innovation for future public health needs...Clin Micro Infect, Theuretzbacher, here.

September 2017 
PAC CARB report on incentives including antibiotics, vaccines. 80pp,  here.

2018

January 2018
New study, specter of more bugs resistant to last-line antibiotics, WSJ, here.

February 2018
"Drug Makers Lobby for Antibiotic Incentives," STAT PLUS, here.

For a 23 page FDA white paper, here.
  Required by FDASIA 2012, S. 805.  (See Title VIII, S. 801-806)).
  February 2018:  https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm595264.htm

April 2018
Vital Signs: Containment of novel multi drug resistant organisms.  (CDC) Morbidity Mortality Weekly, 67(13), April 6, 2018.  Here.

June 2018
FDA on:  new paradigms for antibiotic payments. Here.